News Release

Elsevier congratulates editors of Stem Cells: Scientific Facts and Fiction upon receipt of awards

Editors of Stem Cells received the BMA Board of Science Award for the Public Understanding of Science and First Prize in the Basic and Clinical Sciences category during the 2011 BMA Book Awards

Grant and Award Announcement

Elsevier Science & Technology Books

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, congratulates editors Christine Mummery, Ian Sir Wilmut, Anja van de Stolpe, and Bernard Roelen, whose new book, Stem Cells: Scientific Facts and Fiction, has received the British Medical Association Book Award's First Prize in the category of Basic and Clinical Sciences, as well as the BMA Board of Science Award for the Public Understanding of Science. The awards were announced on September 14th at BMA House in London.

Stem Cells: Scientific Facts and Fiction provides the reader background information on stem cells in a clear and well-organized manner. It provides the non-stem cell expert with an understandable review of the history, current state of affairs, and facts and fiction of the promises of stem cells. It distinguishes itself from the multiplicity of websites on the subject of stem cells by being scientifically, politically and ethically neutral, explaining pros and cons for stem cells of every sort with the intention of reaching a wide readership ranging from advanced students and patient advocacy groups to clinicians, specialists and early phase medics in training. By providing the background scientific and social information, it provides readers with the information they require to form their own opinions on the use of stem cells on the basis of facts rather than hype.

The BMA Board of Science Award for the Public Understanding of Science was established in 2006 to further the educational objectives of the Board of Science. "This highly illustrated and imaginatively presented book," said BMA about Stem Cells on their website award page, "provides the non-stem cell expert with a review of the history, current state of affairs, and facts and fiction of the promises of stem cells. Its reviewer commented that it 'reads more like a conversational seminar rather than a standard textbook…. The interviews with prestigious workers in the field help to engage the reader and allow the evidence to be put into context. The many photos add liveliness to the book which, again, makes it very readable.'" In addition to the BMA Board of Science Award for the Public Understanding of Science, Stem Cells was also awarded first prize in the category of Basic and Clinical Sciences.

###

Christine Mummery is at Leiden University Medical Center, Department of Anatomy and Embryology, Leiden, The Netherlands. Ian Sir Wilmut is Director, MRC Centre for Regenerative Medicine. Anja van de Stolpe is at Hubrecht Institute, Vught, The Netherlands. Bernard Roelen is at the Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

About Academic Press

Academic Press has been a leading publisher of scientific books for more than 65 years. For scientific and medical researchers, Academic Press provides high quality scientific reference and academic content. From neuroscience to earth science, Academic Press is committed to publishing a wide variety of superior quality content from today's leading experts.

As an imprint of Elsevier Science & Technology Books, Academic Press offers seamless integration of scientific content with online resources such as SciVerse ScienceDirect books and BrainNavigator, the award-winning product that improves the quality of neuroscience research. The S&T Books' family of imprints includes leaders in the media technology market with Focal Press and computing market with Morgan Kaufmann. Other imprints include CIMA, Newnes, Syngress, William Andrew, Butterworth-Heinemann, Academic Cell, Anderson Press, and Gulf Publishing (www.ElsevierDirect.com/).

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.